We are live on ! Find out more
AG

Advisor Group Portfolio holdings

AUM $14.5B
1-Year Est. Return 24.86%
This Fund
S&P 500
This Quarter Est. Return
-11.22%
1 Year Est. Return
+24.86%
3 Year Est. Return
+39.54%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$10.2B
AUM Growth
+$266M
Cap. Flow
+$1.6B
Cap. Flow %
15.75%
Top 10 Hldgs %
19.6%
Holding
5,482
New
237
Increased
2,510
Reduced
1,723
Closed
201

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$134M
2
VTV icon
Vanguard Value ETF
VTV
+$80.2M
3
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$74.2M
4
HDV
iShares Core High Dividend ETF
HDV
+$63.2M
5
VUG icon
Vanguard Growth ETF
VUG
+$62.6M

Top Sells

Rank Stock Value
1
SPYG icon
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
+$61M
2
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$44.4M
3
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$38.1M
4
JNK icon
State Street SPDR Bloomberg High Yield Bond ETF
JNK
+$29.8M
5
IUSG icon
iShares Core S&P US Growth ETF
IUSG
+$22.4M

Sector Composition

Rank Sector Weight
1 Technology 5.26%
2 Financials 4.59%
3 Healthcare 4.15%
4 Consumer Discretionary 3.48%
5 Industrials 3.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVNW icon
5001
Aviat Networks
AVNW
$262M
$0 ﹤0.01%
4
– –
AYTU icon
5002
AYTU BioPharma
AYTU
$23.2M
– –
0
– –
BAC icon
5003
CALL
Bank of America
BAC
$435B
– –
-13
Closed -$2K
BBW icon
5004
Build-A-Bear
BBW
$423M
$0 ﹤0.01%
20
– –
BCML icon
5005
BayCom
BCML
$346M
– –
-3,027
Closed -$81K
BCRX icon
5006
BioCryst Pharmaceuticals
BCRX
$2.37B
$0 ﹤0.01%
50
– –
BFIN
5007
DELISTED
BankFinancial
BFIN
$0 ﹤0.01%
+8
New +$118
BH icon
5008
Biglari Holdings Class B
BH
$1.2B
– –
-5
Closed -$1K
BIO.B icon
5009
Bio-Rad Laboratories Class B
BIO.B
$0 ﹤0.01%
1
– –
BLRX
5010
BioLineRX
BLRX
$12.3M
– –
0
– –
BNED icon
5011
Barnes & Noble Education
BNED
$412M
$0 ﹤0.01%
1
– –
BOC icon
5012
Boston Omaha
BOC
$429M
– –
-100
Closed -$3K
BPRN icon
5013
Princeton Bancorp
BPRN
$278M
– –
-4
Closed –
BRFS
5014
DELISTED
BRF SA
BRFS
$0 ﹤0.01%
78
– –
CALX icon
5015
Calix
CALX
$2.27B
$0 ﹤0.01%
24
-68
-74% -$592
CASI
5016
DELISTED
CASI Pharmaceuticals
CASI
$0 ﹤0.01%
9
– –
CATO icon
5017
Cato Corp
CATO
$65.9M
$0 ﹤0.01%
8
– –
CBZ icon
5018
CBIZ
CBZ
$2.29B
$0 ﹤0.01%
19
– –
CEPU
5019
Central Puerto
CEPU
$2.22B
$0 ﹤0.01%
+10
New +$95
CHAU icon
5020
Direxion Daily CSI 300 China A Share Bull 2X ETF
CHAU
$90.3M
– –
-100
Closed -$2K
MBAI
5021
Check-Cap
MBAI
$8.5M
$0 ﹤0.01%
8
– –
CIA icon
5022
Citizens
CIA
$245M
$0 ﹤0.01%
29
– –
CMCL icon
5023
Caledonia Mining Corp
CMCL
$360M
$0 ﹤0.01%
40
– –
CNOB icon
5024
Center Bancorp
CNOB
$1.63B
– –
-12
Closed –
CNYA icon
5025
iShares MSCI China A ETF
CNYA
$221M
– –
-300
Closed -$8K
199 200
201
202 203

Similar funds

LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
HAM
Highstreet Asset Management London, Ontario, Canada $2.22B AUM 20.88% 1-Year Est. Return
CM
CS McKee Pittsburgh, Pennsylvania $1.09B AUM 31.33% 1-Year Est. Return
TRAM
Tuscan Ridge Asset Management Chicago, Illinois $984M AUM 25.8% 1-Year Est. Return
MP
Manikay Partners New York $893M AUM 55.39% 1-Year Est. Return
CONA
Capital One National Association New York $756M AUM
CBU
CIBC Bank USA Chicago, Illinois $756M AUM 24.68% 1-Year Est. Return

Advisor Group's Q4 2018 Portfolio in Review

As of Q4 2018, Advisor Group held 5,482 positions worth $10.2B, up 2.7% from $9.92B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Advisor Group deployed $1.6B of net new capital in Q4 2018, opening 237 new positions and adding to 2,510 existing holdings. Its largest new stake was AnaptysBio: 122,700 shares worth $7.83M.

By sector, the portfolio is most concentrated in Technology at 5.3% of assets, down from 6.5% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR Portfolio S&P 500 Growth ETF, an estimated $61M trimmed.

  • Advisor Group's largest Q4 2018 buy was AnaptysBio: 122,700 shares worth $7.83M.
  • Advisor Group added most to iShares Core S&P 500 ETF in Q4 2018, an estimated $134M increase.
  • Advisor Group's biggest Q4 2018 reduction was State Street SPDR Portfolio S&P 500 Growth ETF, cutting an estimated $61M.
  • Advisor Group fully exited Corporate Capital Trust, Inc. in Q4 2018, selling an estimated $12.1M.
  • Advisor Group's ten largest holdings make up 20% of its $10.2B portfolio in Q4 2018.
  • Advisor Group opened 237 new positions and closed 201 in Q4 2018.
  • Advisor Group's portfolio value rose 2.7% quarter-over-quarter to $10.2B.

Based on Advisor Group's 13F filing for Q4 2018, filed 11 Feb 2019.